Sampo plc’s share buybacks 23 September 2024
September 24, 2024 01:30 ET
|
Sampo plc
Sampo plc, stock exchange release, 24 September 2024 at 8:30 am EEST Sampo plc’s share buybacks 23 September 2024 On 23 September 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22)...
BGHL (GBP): NAV(s)
September 24, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
BGHL (EUR): NAV(s)
September 24, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis
September 24, 2024 01:15 ET
|
Basilea Pharmaceutica AG, Allschwil
Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Belships ASA: Key information relating to the cash dividend to be paid by Belships ASA
September 24, 2024 01:01 ET
|
Belships ASA
Oslo, 24 September 2024 The distribution will be made as an ordinary dividend Dividend amount: NOK 1.00 per share Declared currency: NOK Last day including right: 25 September 2024 Ex date: 26...
Nature Reviews Highlights Significant Successes of Antibiotic Collaboration and Calls for Sustainable R&D Funding Schemes
September 24, 2024 01:00 ET
|
BioVersys
BASEL, Switzerland, Sept. 24, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for...
EfTEN REAL ESTATE FUND AS NOTICE CALLING THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
September 24, 2024 01:00 ET
|
EfTEN Real Estate Fund AS
The Management Board of EfTEN Real Estate Fund AS (registry code 12864036; seat Tallinn, A. Lauteri 5) calls the extraordinary general meeting of shareholders on 16 October 2024 at 15:00. ...
Start of Day Message
September 24, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 24 Sep. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Santhera Announces Acceptance by Swissmedic of Marketing Authorization Application for AGAMREE® (vamorolone) in Duchenne Muscular Dystrophy
September 24, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Pratteln, Switzerland, September 24, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that Swissmedic, the Swiss Agency for Therapeutic Products, has accepted for review the marketing...
Belships ASA: Extraordinary dividend payment
September 24, 2024 01:00 ET
|
Belships ASA
Oslo, 24 September 2024 The sale of the debt-free supramax vessels BELFRIEND and BELTIDE has been completed and the sale proceeds of USD 56.6m have been received. Due to the Company's strong...